110 related articles for article (PubMed ID: 27861728)
1. Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype.
Wobser M; Maurus K; Roth S; Appenzeller S; Weyandt G; Goebeler M; Rosenwald A; Geissinger E
Br J Dermatol; 2017 Aug; 177(2):564-566. PubMed ID: 27861728
[No Abstract] [Full Text] [Related]
2. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
Carlsen ED; Swerdlow SH; Cook JR; Gibson SE
Am J Surg Pathol; 2019 Oct; 43(10):1403-1412. PubMed ID: 31464711
[TBL] [Abstract][Full Text] [Related]
3. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
4. Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma.
Brenner I; Roth S; Flossbach L; Wobser M; Rosenwald A; Geissinger E
Br J Dermatol; 2015 Dec; 173(6):1527-8. PubMed ID: 26099629
[No Abstract] [Full Text] [Related]
5. Current concepts on cutaneous MALT lymphomas.
Fernandez-Flores A
Am J Dermatopathol; 2013 Jun; 35(4):477-84. PubMed ID: 23694824
[TBL] [Abstract][Full Text] [Related]
6. A Case Report of Small Lymphocytic Lymphoma Mimicking Primary Cutaneous Marginal Zone Lymphoma With Plasmacytic Differentiation.
Smith SDB; Aggarwal A; Chen W; Nava VE
Am J Dermatopathol; 2021 Oct; 43(10):730-731. PubMed ID: 33606375
[No Abstract] [Full Text] [Related]
7. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous marginal zone lymphomas.
Swerdlow SH
Semin Diagn Pathol; 2017 Jan; 34(1):76-84. PubMed ID: 27986434
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous marginal zone B-cell lymphomas: are they different from other extranodal marginal zone B-cell lymphomas?
Ferenczi K
J Cutan Pathol; 2009 Jun; 36(6):715-7. PubMed ID: 19515055
[No Abstract] [Full Text] [Related]
10. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
11. Nodal marginal zone lymphoma: mutation status analyses of CD79A, CD79B, and MYD88 reveal no specific recurrent lesions.
Gurth M; Bernard V; Bernd HW; Schemme J; Thorns C
Leuk Lymphoma; 2017 Apr; 58(4):979-981. PubMed ID: 27687087
[No Abstract] [Full Text] [Related]
12. Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma.
Wang E; Stoecker M; Burchette J; Rehder C
Hum Pathol; 2012 Nov; 43(11):2001-11. PubMed ID: 22607703
[TBL] [Abstract][Full Text] [Related]
13. MYD88 somatic mutations in MALT lymphomas.
Li ZM; Rinaldi A; Cavalli A; Mensah AA; Ponzoni M; Gascoyne RD; Bhagat G; Zucca E; Bertoni F
Br J Haematol; 2012 Sep; 158(5):662-4. PubMed ID: 22640364
[No Abstract] [Full Text] [Related]
14. [Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases].
Bathelier E; Thomas L; Balme B; Coiffier B; Berger F; Ffrench M; Salles G; Dalle S
Ann Dermatol Venereol; 2008 Nov; 135(11):748-52. PubMed ID: 19061653
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
16. Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient.
Fujiwara M; Morales AV; Seo K; Kim YH; Arber DA; Sundram UN
Am J Dermatopathol; 2013 Feb; 35(1):11-8. PubMed ID: 22588547
[TBL] [Abstract][Full Text] [Related]
17. Metachronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and peripheral T-cell lymphoma unspecified: histologic, immunophenotypic, and molecular documentation.
Venizelos J; Papadopoulos N; Lambropoulou M; Nikolaidou S; Bolioti S; Tamiolakis D
Onkologie; 2005 Aug; 28(8-9):423-6. PubMed ID: 16160405
[TBL] [Abstract][Full Text] [Related]
18. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
[TBL] [Abstract][Full Text] [Related]
19. Primary Cutaneous B-Cell Lymphoma Complicated by Clonal T-Cell Populations: A Diagnostic Dilemma.
Symes E; Dominiak N
Am J Dermatopathol; 2021 Jun; 43(6):454-458. PubMed ID: 33481377
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity.
Ambrosio MR; De Falco G; Rocca BJ; Barone A; Amato T; Bellan C; Lazzi S; Leoncini L
Virchows Arch; 2015 Oct; 467(4):471-80. PubMed ID: 26286813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
